Notice ID: 8f15039ad8ba4a7e9e7b74d8c02bdef6JustificationAwardedArchived
Q301--ThyroSeq v3 Genomic Classifier Base | 583C62031
Awarded on October 3, 2025. Full description on SAM.gov.
Awarded tounder 36C25026C0012 (source: SAM.gov award notice)• $386.8K
Overview
- Posted
- October 6, 2025
- Notice type
- Justification
- NAICS
- 621511: Medical Laboratories
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 250-NETWORK CONTRACT OFFICE 10 (36C250)
- Last updated
- Nov 7, 2026
- First published
- Last updated on SAM.gov
- Award date
- Oct 3, 2025
- Award amount (SAM.gov award notice)
- $386.8K
Identifiers
- Solicitation number
- 36C25025Q0934
- Notice ID
- 8f15039ad8ba4a7e9e7b74d8c02bdef6
Description
Justification and Approval for the award of the ThyroSeq V3 Genomic Classifier thyroid testing with the Richard L. Roudebush VA Medical Center.
Award Overview
Award Number
36C25026C0012
Award Amount (SAM.gov award notice)
$386.8K
Award Date
Oct 3, 2025
Awardee
Awardee Address
RYE BROOK, NY 10573, NY
Delivery Order Number
36C25026C0012
Line Item Number
All
Original Solicitation
Notice ID: 8f15039ad8ba4a7e9e7b74d8c02bdef6
Posted Date: Oct 6, 2025
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $94.0KSigned Nov 12, 2026
- $20.0KSigned Nov 10, 2026
- $267.8KSigned Oct 22, 2026
- —Signed Oct 6, 2026
- $105.0KSigned Oct 1, 2026
Contacts
Contracting Officer
Primary Contact
Documents
Lifecycle
- 6Version 6Special NoticeArchived
Q301--ThyroSeq v3 Genomic Classifier Sole Source Notice
- 4Version 4JustificationArchivedCurrent
Type changed from Special Notice to Justification
Q301--ThyroSeq v3 Genomic Classifier Base | 583C62031
Other notices for this solicitation
- AwardedRelated noticeOct 6, 2025
Q301--ThyroSeq v3 Genomic Classifier Richard L. Roudebush VA Medical Center Indianapolis, IN 46202
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
78% | Awarded | Open | |
See attached | 75% | Awarded | Open |
Page 2 of 2 The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract (Period of Performance: Base plus four option years) to Decipher Corp. for the procurement of Decipher Genomic Prostate Cancer Testing. The testing will include: all related CPT codes, all labor, supplies, equipment, insurance, and supervision to provide the items. The off-site testing will be administered by the VA North Texas Healthcare System, Pathology & Laboratory Medicine Service, 4500 S. Lancaster Rd., Dallas, TX 75216. Item Description 0001 Provide sendout reference laboratory testing not performed in-house at VANTHCS' Pathology & Laboratory Medicine Service Lab. Test will encompass all CPT codes. Contractor will provide all labor, supplies, equipment, insurance, and supervision to provide the items. Items are to be ordered on an as needed basis exact quantities of each item cannot be determined in advance as they are based upon physician's orders. This test provides prognostic information to help guide and personalize the treatment of prostate cancer. Test predicts 5yr Metastasis and 10yr cancer-related mortality in localized prostate cancer. Total annual estimated test volume is 15. The proposed sole source procurement will be made by a pricing agreement with Decipher Corp., based upon pricing from previous contracts. The requesting activity states the off-site testing agreement is for genomic prostate cancer testing; required for the testing of post-surgery oncology patients. The sole source justification request submitted by the requesting activity stated that a sole source is required because they require genomic prostate cancer testing for patients who have previously undergone surgery to determine the likelihood of the cancer reoccurrence. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within five (5) days from the publication of this notice, a contract will be issued to Decipher Corp., without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services will Satisfy Agency Needs. All responsible sources that feel they should be considered qualified to provide the above-mentioned products may submit a response to this notice (by the response due date shown above) to Susan.Flores2@va.gov. The information provided shall include detailed (and relevant) documentation to allow the government to perform adequate market research and make a proper determination. A determination by the government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. REQUESTS FOR A SOLICITATION WILL NOT RECEIVE A RESPONSE. | 75% | Special Notice | 05/11/2026 |
DEPARTMENT OF VETERANS AFFAIRS Network Contracting Office 17 Notice of Intent to Sole Source | CareDx AlloMap Heart and AlloSure Heart Testing Services NOTICE OF INTENT TO SOLE SOURCE OPEN-MARKET COMMERCIAL SERVICES AlloMap Heart and AlloSure Heart Laboratory Testing Services Agency Department of Veterans Affairs Contracting Office Network Contracting Office 17 (NCO 17) Requiring Activity VA North Texas Health Care System (VANTHCS) Notice Type Special Notice Notice of Intent to Sole Source Posting Date October 5, 2026 Response Deadline October 15, 2026, at 4:00 p.m. Central Time Anticipated Award Date On or before June 2, 2027 NAICS 621511 Medical Laboratories PSC Q301 Medical Laboratory Testing Set-Aside None Place of Performance VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216 Notice The Department of Veterans Affairs (VA), Network Contracting Office 17, intends to solicit and negotiate on a sole-source basis with CareDx, Inc., 8000 Marina Boulevard, Brisbane, California 94005, for commercial reference-laboratory testing services for the VA North Texas Health Care System. The contemplated action will be conducted as an open-market commercial-service acquisition under Revolutionary FAR Overhaul (RFO) FAR Part 12. The decision to restrict competition will be documented in accordance with RFO FAR 12.102. This notice is not a solicitation and does not constitute a request for quotations or proposals. A solicitation is not available through this notice. However, all responsible sources may submit a capability statement and, if desired, a quotation or proposal. The VA will consider each timely response before determining whether to proceed with the contemplated sole-source acquisition. Requirement The contractor shall provide AlloMap Heart and AlloSure Heart blood-testing services for Veteran heart-transplant patients. The services support noninvasive monitoring of transplant stability and potential rejection in conjunction with standard clinical assessment. Estimated annual volume: 10 AlloMap Heart tests and 10 AlloSure Heart tests. Quantities are estimates and do not guarantee a minimum number of tests. Provide all labor, testing, materials, equipment, specimen supplies, preservatives, requisition forms, special instructions, packaging guidance, and other resources necessary for performance. Provide training to VANTHCS personnel on specimen handling and packaging, and provide specimen collection through commercial laboratory or mobile-draw sites for selected assays when ordered through the contractor s portal. Perform testing within current published turnaround times and provide complete results, status support, technical consultation, and account support. Maintain all required licenses, certifications, and accreditations, including compliance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA), applicable laboratory-accreditation requirements, privacy requirements, and VA information-security requirements. Provide services during the anticipated base period and four option periods shown below. Performance Period Dates Base Period June 3, 2027 June 2, 2028 Option Period 1 June 3, 2028 June 2, 2029 Option Period 2 June 3, 2029 June 2, 2030 Option Period 3 June 3, 2030 June 2, 2031 Option Period 4 June 3, 2031 June 2, 2032 Basis for Intended Source CareDx, Inc. has represented in a letter dated June 10, 2026, that it is the sole-source provider of AlloMap Heart and AlloSure Heart testing services. CareDx further represented that AlloMap Heart is the only heart gene-expression testing service available on the market and that HeartCare, which combines AlloMap Heart and AlloSure Heart, is the only combined heart gene-expression and donor-derived cell-free DNA testing service available on the market. Based on the proprietary nature of the required assays and the information currently available to VA, CareDx is the only source known to be capable of satisfying the requirement without substituting different tests or methodologies. Response Requirements An interested source must submit sufficient, specific, and verifiable information demonstrating its present ability to perform the complete requirement. Marketing literature or an unsupported statement of capability is not sufficient. The response shall include: Legal business name, physical address, point of contact, telephone number, email address, Unique Entity ID, CAGE code, and business size and socioeconomic status under NAICS 621511. Evidence that the respondent can furnish and perform both AlloMap Heart and AlloSure Heart testing services, including any license, ownership right, authorization, or enforceable agreement permitting the respondent to provide the proprietary assays for the entire contemplated period of performance. A point-by-point explanation of how the respondent will satisfy the attached Statement of Work, including estimated quantities, specimen supplies, collection support, handling and shipping, published turnaround times, result reporting, technical consultation, customer support, invoicing, records management, privacy, and information-security requirements. Copies or identifying information for current CLIA certification, applicable laboratory accreditation, licenses, and other required professional credentials. Identification of the laboratory location where each assay will be performed and disclosure of all proposed subcontractors or reference laboratories. Relevant past performance demonstrating successful performance of the same or substantially similar heart-transplant molecular testing services. Identification and technical support for any proposed alternative methodology, including clinical validation and a clear explanation of how the alternative meets every functional and clinical requirement without increasing risk, delay, or burden to Veteran patients or VA clinicians. Submission Instructions Responses are due no later than October 15, 2026, at 4:00 p.m. Central Time. Submit responses electronically to the Primary Point of Contact identified in the SAM.gov notice (ognian.ivanov@va.gov), please include CareDx AlloMap/AlloSure Heart Sole-Source Notice Response in the subject line. Responses shall be in Microsoft Word or searchable PDF format and should not exceed 10 pages, excluding licenses, certifications, and supporting technical validation. Clearly mark any proprietary information. The Government will not reimburse any costs incurred in preparing or submitting a response. Submission of a response does not create any right to an award and does not obligate the Government to issue a solicitation, conduct discussions, or award a contract. Government Determination The information received will be used solely to determine whether a competitive acquisition is feasible. A determination not to compete this proposed action, based on responses to this notice, is solely within the discretion of the Government. If no timely response demonstrates that another responsible source can satisfy the complete requirement, VA intends to solicit and negotiate only with CareDx, Inc. | 75% | Special Notice | 10/15/2026 |
Page 2 of 2 Notice Type: Special Notice of Intent to Sole Source This is a SPECIAL NOTICE ANNOUNCEMENT ONLY. The Department of Veteran Affairs, VISN 2 Network Contracting Office intends to award a sole source contract for the Buffalo VAMC, New York. This proposed contract action is for a service in which the Government intends to award a firm fixed-price STAT Reference Lab Testing Services contract with only one source; Kaleida Health, 726 Exchange Street, Buffalo, NY 14210 under the authority Federal Acquisition Regulation (FAR) Part 6.302-1 Only One Responsible Source. Places of Performance: Department of Veterans Affairs Buffalo VAMC Laboratory Department 3495 Bailey Avenue Buffalo, NY 14215 Purpose and Objectives: The intent of this Special Notice is to identify potential offerors capable of providing analysis, monitoring, and reporting findings of laboratory and pathology tests for the VA Upstate NY Healthcare System at Buffalo VAMC. Contractor shall provide STAT laboratory testing on Veteran patient specimens seven days a week, including holidays, 24 hours a day. Contractor laboratory requires mandatory licensing and accreditation possessing a NYS Department of Health Clinical Laboratory Permit, Clinical Laboratory Improvement Amendments (CLIA) License and College of American Pathologists (CAP) Accreditation. General Requirements The Contractor must be able to perform all of the required testing as follows: a. Contractor will provide STAT laboratory testing on patient specimens seven days a week, including holidays, 24 hours a day. b. VA will be responsible for specimen collection, preparation, preservation, and delivery, except for semen analysis which will be delivered by the patient to contractor location. c. Sample analysis for routine laboratory testing will be performed as soon as possible by the contractor. Results will be faxed to the VA with originals to follow by mail or courier. d. Sample analysis for STAT laboratory testing will be reported within two hours after sample delivery. Results will be reported via phone and faxed, with originals to follow by mail or courier. e. Tests in addition to the specified list may be required on a rare occasion if a need arises to send a sample to be tested locally for expedited patient care. This will be limited to testing that can be performed in house at the contractor site. Response: Responses to this Special Notice should be able to demonstrate the firm's ability, capability, and responsibility to deliver the service listed above. The purpose of this Special Notice announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Service Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, 8(a), HubZone and other Small Businesses interested and capable of providing the services described above. Documentation of technical expertise must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area expertise and experience to compete for this acquisition. No funds have been authorized, appropriated, or received for this effort. Responses should include the following information: Business name, address, business size and Socioeconomic Category (HUBZone, 8(a), Service Disabled Veteran, Small Business, Large Business, etc.), and point of contact to include e-mail address and telephone number. All offerors must be registered in the System for Award Management (www.sam.gov) and Representations and Certifications must be completed prior to any future award. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to provide STAT reference lab send-out testing services. Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this sources sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511 ($41.5 Million). Any offeror capable of providing this service shall notify the Contracting Officer by email within 15 calendar days from the date of the publication of this Special Notice. All information is to be submitted via e-mail to: Michelle.Harsch@va.gov | 74% | Special Notice | 11/20/2026 |
Additional Details
Solicitation Number
36C25025Q0934
Archive Date
Nov 5, 2025
Office Address
DAYTON, OH, 45428